NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 677369 | Null | 0.0237269271456697 | 0.31390616 |
NSC 679240 | Null | 0.0237269271456697 | -0.31749438 |
NSC 679261 | Null | 0.0237269271456697 | -0.10062455 |
NSC 685964 | Null | 0.0237269271456697 | 0.16641118 |
NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0237269271456697 | 0.242881 |
NSC 693037 | Null | 0.0237269271456697 | 0.050179155 |
NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0237269271456697 | 0.066888444 |
NSC 715407 | Null | 0.0237269271456697 | 0.028705208 |
NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.0237269271456697 | 0.11707201 |
NSC 725098 | Null | 0.0237269271456697 | -0.17592257 |